Cargando…

CHK2 is involved in the p53-independent radiosensitizing effects of valproic acid

Radiotherapy is an effective treatment for the majority of types of localized solid cancer. However, the risk of side effects to the surrounding normal tissues limits radiotherapeutic approaches. Whilst the mechanism of action of valproic acid, an inhibitor of histone deacetylase, remains unknown, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choo, Dong Wan, Goh, Sung Ho, Cho, Young Woo, Baek, Hye Jung, Park, Eun Jung, Motoyama, Noboru, Kim, Tae Hyun, Kim, Joo Young, Kim, Sang Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403276/ https://www.ncbi.nlm.nih.gov/pubmed/28454438 http://dx.doi.org/10.3892/ol.2017.5792

Ejemplares similares

ATM/CHK/p53 Pathway Dependent Chemopreventive and Therapeutic Activity on Lung Cancer by Pterostilbene
por: Lee, Hani, et al.
Publicado: (2016)

In Vitro and In Vivo Radiosensitizing Effect of Valproic Acid on Fractionated Irradiation
por: Chie, Eui Kyu, et al.
Publicado: (2015)

MK-8776, a novel chk1 kinase inhibitor, radiosensitizes p53-defective human tumor cells
por: Bridges, Kathleen A., et al.
Publicado: (2016)

Rad53- and Chk1-Dependent DNA Damage Response Pathways Cooperatively Promote Fungal Pathogenesis and Modulate Antifungal Drug Susceptibility
por: Jung, Kwang-Woo, et al.
Publicado: (2019)

Valproic acid promotes radiosensitization in meningioma stem-like cells
por: Chiou, Hsin-Ying Clair, et al.
Publicado: (2015)

Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid
por: Lee, Soo-Yun, et al.
Publicado: (2015)

Valproic Acid Increases Expression of Neuronal Stem/Progenitor Cell in Spinal Cord Injury
por: Bang, Woo-Seok, et al.
Publicado: (2013)

Chk2 and p53 Are Haploinsufficient with Dependent and Independent Functions to Eliminate Cells after Telomere Loss
por: Kurzhals, Rebeccah L., et al.
Publicado: (2011)

Targeting of Chk2 as a countermeasure to dose-limiting toxicity triggered by topoisomerase-II (TOP2) poisons
por: Gokare, Prashanth, et al.
Publicado: (2016)

The Neuroprotective Effect of Treatment of Valproic Acid in Acute Spinal Cord Injury
por: Yu, Song-Hee, et al.
Publicado: (2012)

Gene signature for prediction of radiosensitivity in human papillomavirus-negative head and neck squamous cell carcinoma
por: Kim, Su Il, et al.
Publicado: (2020)

Valproic Acid Downregulates the Expression of MGMT and Sensitizes Temozolomide-Resistant Glioma Cells
por: Ryu, Chung Heon, et al.
Publicado: (2012)

Transglutaminase 2 Inhibitor KCC009 Induces p53-Independent Radiosensitization in Lung Adenocarcinoma Cells
por: Huayin, Sheng, et al.
Publicado: (2016)

Valproic Acid-induced Hyperammonemic Encephalopathy Promoted by Levetiracetam
por: Roh, Sook Young, et al.
Publicado: (2014)

HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1
por: Moses, Niko, et al.
Publicado: (2020)

Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer
por: Hwang, Hye Jung, et al.
Publicado: (2020)

Treadmill exercise ameliorates motor dysfunction through inhibition of Purkinje cell loss in cerebellum of valproic acid-induced autistic rats
por: Cho, Han-Sam, et al.
Publicado: (2016)

Chk1 deficiency in the mouse small intestine results in p53-independent crypt death and subsequent intestinal compensation
por: Greenow, Kirsty R., et al.
Publicado: (2009)

Chk1, Chk2, is the amplifier on?
por: Dove, Alan W.
Publicado: (2001)

Histone deacetylase inhibitor, valproic acid, radiosensitizes the C6 glioma cell line in vitro
por: ZHOU, YONG, et al.
Publicado: (2014)

Erratum to: Genetic Screen for Genes Involved in Chk2 Signaling in Drosophila
por: Park, Suk-Young, et al.
Publicado: (2014)

Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer
por: Nair, Jayakumar, et al.
Publicado: (2020)

Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1
por: Ahmed, A, et al.
Publicado: (2011)

The Chk1 inhibitor MK-8776 increases the radiosensitivity of human triple-negative breast cancer by inhibiting autophagy
por: Zhou, Zhi-rui, et al.
Publicado: (2017)

Keeping RelApse in Chk: molecular mechanisms of Chk1 inhibitor resistance in lymphoma
por: Black, Elizabeth M., et al.
Publicado: (2022)

The Role of Wild-Type p53 in Cisplatin-Induced Chk2 Phosphorylation and the Inhibition of Platinum Resistance with a Chk2 Inhibitor
por: Liang, Xiaobing, et al.
Publicado: (2011)

Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status
por: Hafsi, Hind, et al.
Publicado: (2018)

Zoledronic acid is an effective radiosensitizer in the treatment of osteosarcoma
por: Kim, Eun Ho, et al.
Publicado: (2016)

Transcriptomic analysis in the striatum reveals the involvement of Nurr1 in the social behavior of prenatally valproic acid-exposed male mice
por: Kim, Hyunju, et al.
Publicado: (2022)

Exploring the Validity of Valproic Acid Animal Model of Autism
por: Mabunga, Darine Froy N., et al.
Publicado: (2015)

Comparison of computed tomography features between follicular neoplasm and nodular hyperplasia
por: Lee, Kwang Hwi, et al.
Publicado: (2016)

Chk1 inhibition in p53-deficient cell lines drives rapid chromosome fragmentation followed by caspase-independent cell death
por: Del Nagro, Christopher J, et al.
Publicado: (2014)

Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer
por: Jang, Na Young, et al.
Publicado: (2015)

Caspase-3/7-mediated Cleavage of β2-spectrin is Required for Acetaminophen-induced Liver Damage
por: Baek, Hye Jung, et al.
Publicado: (2016)

Comparative analysis of background EEG activity in juvenile myoclonic epilepsy during valproic acid treatment: a standardized, low-resolution, brain electromagnetic tomography (sLORETA) study
por: Moon, Ja-Un, et al.
Publicado: (2022)

Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabine
por: Duong, Hong-Quan, et al.
Publicado: (2013)

CTP sensing and Mec1(ATR)-Rad53(CHK1/CHK2) mediate a two-layered response to inhibition of glutamine metabolism
por: Ajazi, Arta, et al.
Publicado: (2022)

A novel Chk1-binding peptide that enhances genotoxic sensitivity through the cellular redistribution of nuclear Chk1
por: Kim, Kwang Seok, et al.
Publicado: (2016)

A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
por: Gill, Martin R., et al.
Publicado: (2016)

Chronic Central Administration of Ghrelin Increases Bone Mass through a Mechanism Independent of Appetite Regulation
por: Choi, Hyung Jin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_os176cfjil0qbo8p4ujuuq2tqs